Friedland, Germany

Oliver Wirths


 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Oliver Wirths: Innovator in Alzheimer's Research

Introduction

Oliver Wirths is a notable inventor based in Friedland, Germany. He has made significant contributions to the field of Alzheimer's research, particularly through his innovative patents. With a total of two patents to his name, Wirths is recognized for his work in developing novel therapeutic approaches to combat amyloid-related disorders.

Latest Patents

Wirths' latest patents include a transgenic mouse model expressing amyloid β 4-42 peptide. This invention describes a novel transgenic mouse model for the common sporadic form of Alzheimer's disease. The invention relates to a nucleotide sequence encoding Aβ 4-42 in functional linkage with at least a promoter, signal peptide sequence, and a polyadenylation signal sequence. This model is crucial for screening methods related to Alzheimer's disease.

Another significant patent is for monoclonal antibodies targeting amyloid beta oligomers. This invention involves binding molecules capable of specifically recognizing soluble oligomers of N-terminal truncated Aβ starting with pyroglutamate (Aβ1E). It includes pharmaceutical compositions comprising these antibodies and their respective therapeutic uses. The invention also provides methods for inhibiting the formation of Aβ1E oligomers and diagnosing diseases associated with amyloidogenesis.

Career Highlights

Throughout his career, Oliver Wirths has worked with several esteemed institutions. He has been associated with Georg-August-Universität Göttingen, a public law foundation, as well as Universitätsmedizin Göttingen. Additionally, he has contributed to Synaptic Systems GmbH, a company focused on neurobiological research, development, and production.

Collaborations

Wirths has collaborated with notable colleagues, including Thomas Bayer and Henrik Martens. Their combined expertise has further advanced the research in the field of Alzheimer's disease.

Conclusion

Oliver Wirths is a prominent figure in Alzheimer's research, with innovative patents that contribute to understanding and treating amyloid-related disorders. His work continues to impact the scientific community and offers hope for future therapeutic developments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…